Physician

Kimberly Ann Licciardi, MD

According to 2025 Medicare claims, Kimberly Licciardi, MD (NPI: 1104976885) practices ophthalmology in the Manchester-Nashua, NH market, with the plurality of this provider's patient population coming from Hillsborough, NH. This provider's primary affiliated billing organization is NH EYE ASSOCIATES PLLC (NPI: 1518044213; TIN: 020309807) and primary practice location at 03102-5210. Licciardi is affiliated with the Elliot Health System ACO LLC (ACO ID: A5640) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Licciardi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,075 traditional Medicare patients, billed 3,318 HCPCS/CPT codes, and received $325,257 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,663 prescription claims across 543 beneficiaries totaling $155,048 in drug costs, led by Restasis (Cyclosporine). DME data shows 24 claims. Open Payments data shows 3 records totaling $64. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,094	2,775	$326,190
2016	934	2,457	$235,748
2017	1,039	2,892	$329,904
2018	1,099	3,105	$397,396
2019	1,274	3,346	$405,123
2020	1,192	3,029	$304,052
2021	1,175	3,413	$357,154
2022	1,064	3,215	$335,451
2023	1,087	3,326	$348,701
2024	1,075	3,318	$325,257

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	344	1,562	$133,277
2016	326	1,795	$150,430
2017	383	2,250	$191,900
2018	467	2,484	$230,631
2019	494	2,338	$238,216
2020	507	2,585	$234,658
2021	584	3,001	$225,696
2022	523	2,835	$196,417
2023	483	2,510	$178,019
2024	543	2,663	$155,048

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	93	93	$4,405
2016	58	58	$2,632
2017	76	76	$3,898
2018	138	138	$8,418
2019	115	116	$7,163
2020	44	44	$3,072
2021	64	66	$4,607
2022	50	52	$3,788
2023	36	36	$2,560
2024	24	24	$1,811

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	593	600	$83
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	365	454	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	338	483	$61
92083	Exam of visual field with extended testing	278	286	$44
92133	Imaging of optic nerve	369	564	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	34	1,890	$40,148
Xiidra	Lifitegrast	14	900	$20,498
Cyclosporine	Cyclosporine	23	1,410	$15,597
Simbrinza	Brinzolamide/Brimonidine Tart	33	1,628	$9,129
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	444	29,818	$7,650

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	11	11	$1,110
V2020	Frames, purchases	N	13	13	$701

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$64	Bausch & Lomb Americas Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kimberly Ann Licciardi, MD?

Tedicare shows public-source Medicare data for Kimberly Ann Licciardi, MD (NPI 1104976885), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kimberly Ann Licciardi, MD have ACO affiliation data?

Kimberly Ann Licciardi, MD is shown with ACO affiliation data for Elliot Health System ACO LLC (MSSP, ACO ID A5640) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Kimberly Ann Licciardi, MD?

Kimberly Ann Licciardi, MD is linked to NH EYE ASSOCIATES PLLC (billing NPI 1518044213) in the available physician profile data.

Does Kimberly Ann Licciardi, MD have Open Payments data?

Kimberly Ann Licciardi, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.